AbbVie Inc. Accrued Liabilities 2012-2026 | ABBV
Beta
What is accrued liabilities?
Accrued liabilities are expenses that have been incurred but not yet paid, such as wages, interest, and taxes payable.
What is AbbVie Inc.'s current accrued liabilities?
AbbVie Inc. (ABBV) annual accrued liabilities for 2025 was $34.73B, a 8.73% increase from 2024. AbbVie Inc. accrued liabilities for the quarter ending March 31, 2026 was $33.77B.
What was AbbVie Inc.'s accrued liabilities in 2024?
AbbVie Inc. annual accrued liabilities for 2024 was $31.95B, a 4.23% increase from 2023.
What was AbbVie Inc.'s accrued liabilities in 2023?
AbbVie Inc. annual accrued liabilities for 2023 was $30.65B, a 20.66% increase from 2022.
What is AbbVie Inc.'s 5-year accrued liabilities CAGR?
AbbVie Inc. accrued liabilities grew at a compound annual growth rate (CAGR) of 11.50% from FY2020 to FY2025, going from $20.16B to $34.73B over 5 years.
Accrued Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+11.5%
FY2020
$20.16B
→
FY2025
$34.73B
1213141516171819202122232425
5 years selected
Accrued Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $34.73B | +8.7% | 10-K |
| FY2024 | $31.95B | +4.2% | 10-K |
| FY2023 | $30.65B | +20.7% | 10-K |
| FY2022 | $25.40B | +11.9% | 10-K |
| FY2021 | $22.70B | +12.6% | 10-K |
| FY2020 | $20.16B | +70.4% | 10-K |
| FY2019 | $11.83B | -0.8% | 10-K |
| FY2018 | $11.93B | +16.7% | 10-K |
| FY2017 | $10.23B | +9.0% | 10-K |
| FY2016 | $9.38B | +10.8% | 10-K |
| FY2015 | $8.46B | +21.7% | 10-K |
| FY2014 | $6.95B | +7.8% | 10-K |
| FY2013 | $6.45B | +12.5% | 10-K |
| FY2012 | $5.73B | - | 10-K |
Company: AbbVie Inc.Ticker: ABBVSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →